MAD,PK,PD,tolerability and safety study of MT-1303 in healthy subjects

• Research type

  Research Study

• Full title

  A randomized, double-blind, placebo-controlled study to determine the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple doses of MT-1303 in healthy subjects

• IRAS ID

  79001

• Contact name

  Salvatore Febbraro

• Contact email

  salvatore.febbraro@simbec.co.uk

• Sponsor organisation

  Mitsubishi Pharma Europe Ltd

• Eudract number

  2011-000936-27

• ISRCTN Number

  1

• Research summary

  Research Summary not published at request of researcher

• REC name

  Wales REC 2

• REC reference

  11/WA/0105

• Date of REC Opinion

  13 May 2011

• REC opinion

  Favourable Opinion